Recommendations for the management of postmenopausal vaginal atrophy.
about
The Recent Review of the Genitourinary Syndrome of MenopauseAmerican Cancer Society Colorectal Cancer Survivorship Care GuidelinesMultidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal womenPrescribing menopausal hormone therapy: an evidence-based approachMenopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solutionClinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophyTreating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe drynessVisual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trialPeriurethral Gland Calculus Discovered on Workup for Dyspareunia.Management of Vaginal Atrophy: Implications from the REVIVE Survey.The 2012 hormone therapy position statement of: The North American Menopause Society.Advances in pharmacotherapy for treating female sexual dysfunction.Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophyManagement of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials.Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.Treatment of the genitourinary syndrome of menopause.Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.An update on drugs for the treatment of menopausal symptoms.Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013.Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopauseOvercoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophyGenitourinary syndrome of menopause in five Asian countries: results from the Pan-Asian REVIVE survey.Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause.Barriers to effective treatment of vaginal atrophy with local estrogen therapy.Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy.Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitisA randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiolImpact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy.Inequities in access to HIV prevention services for transgender men: results of a global survey of men who have sex with men.Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy.Vaginal Estrogen Therapy for Patients with Breast Cancer.Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group.Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.
P2860
Q26781733-4E434078-DC4B-4E33-BFB1-292B2A7AC02AQ26782671-4266ECB9-35F2-4EF4-910E-7D87A7D2871EQ26828795-AD37F8AF-5E66-4295-BFDE-48161DE2DF62Q27022920-A3E553AC-1BF8-4028-83B4-2B8CFE47393FQ27025094-06C806F6-A97D-4B5B-B598-68560EC40685Q28066699-96E6068C-07CD-4D4C-A362-E3B81F6AF546Q28079287-BF3706D8-B374-4AF7-B028-AEA096BB57BAQ28743240-82C45111-D9E7-4F04-BE91-4FBF040AF4BCQ30491432-CE41E073-EF38-4689-9748-61D0E0CB305EQ33701696-75AD93CF-280C-4651-8AB5-85DDC5EB3ED4Q33809618-0343D3ED-30C9-431E-BF4C-6F97E326303DQ34161400-06BFA10F-0D2D-4251-A72E-326B0522BE75Q34465301-B56035FC-517A-4A89-AA07-6443236D2959Q35002766-D254DCB3-96EB-4BA8-9156-F69AA7FB096FQ35626394-60CC7EDB-3F90-403D-8193-0FF506A98B28Q35640048-229840D2-D152-4AF5-9492-546338EE620BQ35647630-ACFEB9FE-C02F-455F-A1CB-8E908EFA331FQ35772318-2D272BDE-DA96-4317-B29C-4E7339C85C0DQ35772337-A0308C3D-FE07-43DA-8168-28ADBFFC3696Q35784054-BF444624-7ECD-4136-A6B1-6A65FC43F0ADQ35824414-714603E2-ACB4-45F7-AB07-222B3E7A5623Q35903489-174B844C-5602-4396-900D-5E6ACC99D40FQ36015161-B25F7103-F79A-4AC2-AA72-19486143C00BQ36048582-46E1BD5D-0506-4A68-99E4-C0D9FDED6655Q36049247-0CFE52B7-B944-43E0-B25E-3C84FC2005C9Q36108656-D4D64C01-4503-4F42-B3B0-E71AF1E34E29Q36326412-19D34754-545C-4C52-9B81-8F7FF8AF35A5Q36357799-E0705363-0CEA-4A1D-9242-AE761D206404Q36376192-7F1938A3-543E-48D4-9672-FFD04635E207Q36702052-A3F84F13-628A-46BF-90EB-0ACCD94E1A0CQ36706621-B19D766A-B343-4E0F-8C9D-7BC6A355B6DDQ36824009-9DCC84C6-8427-4F0A-8AB7-E5237E4E31B9Q36846471-75C89109-12A4-4B93-B94B-9FBE80530F15Q37074908-1FABE32E-C72E-45A1-A0A2-CC4DE02458D6Q37104675-97DD380C-523E-4C3E-B5B0-24FF0AD1B89FQ37206316-91AFF30B-A246-46CC-B3C8-7AADF37D3413Q37389691-C02E6E72-AB09-4031-A7EC-5A31BC705158Q37494813-06C68465-BA52-478E-934F-A0DE656F644AQ37552246-93EA6222-8040-4323-B48D-85B7BFB51AC3Q37611334-7A09FF2C-2F51-4FD5-B430-5BEE71C1FF69
P2860
Recommendations for the management of postmenopausal vaginal atrophy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Recommendations for the management of postmenopausal vaginal atrophy.
@en
Recommendations for the management of postmenopausal vaginal atrophy.
@nl
type
label
Recommendations for the management of postmenopausal vaginal atrophy.
@en
Recommendations for the management of postmenopausal vaginal atrophy.
@nl
prefLabel
Recommendations for the management of postmenopausal vaginal atrophy.
@en
Recommendations for the management of postmenopausal vaginal atrophy.
@nl
P2093
P1433
P1476
Recommendations for the management of postmenopausal vaginal atrophy.
@en
P2093
D W Sturdee
International Menopause Society Writing Group
P304
P356
10.3109/13697137.2010.522875
P577
2010-09-30T00:00:00Z